Navigation Links
Novavax and Allergan Terminate Manufacturing Supply Agreement for Estrasorb
Date:10/25/2007

Action allows Novavax to focus on its vaccine business and reduce cash burn

ROCKVILLE, Md., Oct. 25 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that it has agreed with Allergan, Inc. to terminate its manufacturing supply agreement for Estrasorb. Estrasorb was previously licensed by Novavax to Esprit Pharma, Inc. (recently acquired by Allergan, Inc.) in 2006 and is an approved estrogen product for relief of moderate to severe vasomotor symptoms (hot flashes) associated with menopause. Under the termination agreement, Novavax will complete the manufacture of remaining orders for the product and plans to close its Philadelphia manufacturing facility over the next few months. Allergan will continue to sell Estrasorb for the foreseeable future from available inventory.

The goal to exit manufacturing of Estrasorb had been a high priority of the Company's Board and management team since this activity was not strategic to the Company's core vaccine business and was a cash drain to Novavax. The Company had continued manufacturing Estrasorb since it was tied to the product's license agreement. Additionally, Allergan will return to Novavax the rights to develop ESP 210, an investigational drug in Phase II development for the treatment of hypoactive sexual desire disorder.

"We are focused on executing our vaccine business strategy and have previously stated that one of our highest corporate priorities is to divest the Company's various non-vaccine product candidates and technologies. Today's announcement terminating the Estrasorb supply agreement is in line with this corporate priority and will reallocate our cash to our core business, the development of new vaccines," said Dr. Rahul Sing
'/>"/>

SOURCE Novavax, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Novavax Says Bird Flu Vaccines Effective
2. Allergan Introduces ‘Dermal Filler’ for Smile Lins
3. ADHD Medications Terminated By Many Children And Adolescents
4. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
5. South Africa May Start Manufacturing Bird Flu Vaccines
6. Medical LINAC Machine Manufacturing Unit At Khargar
7. Aurobindo Pharma Purchases US Manufacturing Facility
8. The Living Cell – Manufacturing, Protecting and Thrivin
9. FDAs Gesture for Firm Manufacturing Drug for Cushings Syndrome
10. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
11. Supply of Radiopharmaceuticals Hampered by Attacks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...bad cholesterol more effectively than Zocor , ... nearly a year of review, U.S. health officials sa...of the controversial cholesterol-lowering drug Vyt...aid there was no significant difference in carotid...and patients taking the drug Zocor. , But, the ...
(Date:1/8/2009).... 8 Hanger Orthopedic Gr...at throughout the fourth quarter of 2008 it acquir...cky Mountain Orthotic-Prosthetics Center, Riessen,...Coast Orthotics & Prosthetics, and Orthopedic ...dd patient care centers to existing markets in Mai...
(Date:1/8/2009)...Jan. 8 Medivation, Inc.,..., M.D., president and chief,executive officer, wi...re,Conference on Wednesday, January 14, at 10:00 ... in San Francisco. , Dr. Hung will provide ...pment programs for Dimebon for Alzheimer,s and Hun...
(Date:1/8/2009).... 8 A new educational W...dance on drugs, biological products and medical de...Quality,s Centers for Education and Research on Th...of more than a dozen leading research centers nati...formation Network ( CHAIN ) http://www.chainonlin...
Breaking Medicine News(10 mins):Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2Health News:AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics 2
...at should be welcome news for tens of thousands of...ing homes are modernising and entering into tie-up... the growing trend in medical tourism. Half a doz...e up in a year, in addition to scores of smaller g...
...mical component extracted from the cannabis, or ma...ach cramping after eating, according to a study pr... the American College of Gastroenterology. The stu...and placebo on colonic motility and sensation in h...
...rs working in Iraq admit that more than half of th... medical equipment and more experienced staff and ...sim Al Sheibani and colleagues say that as the vio...y is that they cannot treat many of the victims. ...
...ding to the researchers in the U.S., a supplement ...ction of stress linked to metabolic syndrome, a co... diabetes and heart disease. Metabolic syndrome c...on, and unstable glucose and insulin metabolism an...
Other Medicine News:Health News:Agra Hospitals Modernise to Promote Medical Tourism 2Health News:Cinnamon extract in reduction of risk of metabolic syndrome 2
(Date:1/6/2009)...r maintaining a healthy immune system , , PURCH...shed study in Nutrition and Cancer (60(5), 643-6... Osaka, Japan has shown that AHCC (Active Hexose C...creasing the number of dendritic cells (DCs). DCs ...r presenting foreign substances to other immune sy...
(Date:1/6/2009)...wswire/ -- Cequent Pharmaceuticals, a pioneer in t...ased treatments to prevent and treat human disease...d a successful toxicology study of its candidate C... targeting the primary oncogene (beta-catenin, CTN...is an inherited gastrointestinal disease that caus...
(Date:1/5/2009)...ewswire-FirstCall/ -- Micromet, Inc.,(Nasdaq: M...l, proprietary,antibodies for the treatment of ca...des an outlook on key events anticipated for the y...n update on its research and development,programs...16, 2009: Update on several preclinical BiTE antib...
(Date:12/29/2008)...wire-USNewswire/ -- The winner of the 2008 Award f...ounced today by Dr. Peter G. Goldschmidt, Presiden... , , The winner of the annual award was the ...-- for its best practice " IND Regulatory and Mo...nhanced human subjects protection, 2) improved dat...
Breaking Medicine Technology:Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 52008 Human Research Protection Award Recipients Announced 2Depressed Moms Kids at Higher Injury Risk 7613 1Depressed Moms Kids at Higher Injury Risk 7613 2Fry Construction Is Featured in Key Industry Publication 7610 1Fry Construction Is Featured in Key Industry Publication 7610 2InvoiceCHECK Cuts Prescription Benefit Waste 7606 1InvoiceCHECK Cuts Prescription Benefit Waste 7606 2DenteMax Forms Business Alliance With MEDILINQ 7602 1DenteMax Forms Business Alliance With MEDILINQ 7602 2
...lood Pressure in Obese and,Non-Obese Hypertensive ...all/ -- Forest,Laboratories, Inc. today presented ...oled analysis of nebivolol, a selective beta,1-blo...review by,the U.S. Food and Drug Administration (F...he two clinical studies show that,nebivolol demons...
... and 40/25 mg/day and Amlodipine +,Benazepril 5/20...,Hypertension Twenty-Second Annual Scientific Meet...- New data,presented today at the American Society... Meeting (ASH 2007) in Chicago,demonstrated that t...medoxomil/hydrochlorothiazide) was associated with...
Other Medicine Technology:Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 2Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 3Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 2Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 3Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 5Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 6Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 7Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 8
Fixed chair back and armrests, electric lift with 8" (20.3cm) stroke, foot pedal control, choice of upholstery colors. Optional features: 15 tilt mechanism and footrest, locking rotation, sliding arm
Complete with headrest, armrests, footrest and foot switch.
...Large hinged footstep can support patient's full w...ired. Hydraulic base. Patients may be raised and l...chair back or optional corded foot switch. Dual ro... to swivel the chair 330 without changing position...
Heine Beta 200 Streak Retinoscope 3.5v w/Twist Lock for Welch-Allyn style handles.
Medicine Products: